These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 782898)

  • 41. Stereochemical aspects of parasympathomimetics and their antagonists: recent developments.
    Casy AF
    Prog Med Chem; 1975; 11():1-65. PubMed ID: 1129503
    [No Abstract]   [Full Text] [Related]  

  • 42. Physiocochemical, quantum chemical, and other theoretical techniques for the understanding of the pharmacologic action of drugs that affect the central nervous system: psychotropic drugs, narcotics, and narcotic antagonists and anesthetics.
    Kaufman JJ
    Cancer Chemother Rep 2; 1974 Dec; 4(4):49-50. PubMed ID: 4447934
    [No Abstract]   [Full Text] [Related]  

  • 43. Recent physiochemical and quantum chemical studies on drugs of abuse and relevant biomolecules.
    Kaufman JJ
    NIDA Res Monogr; 1978; (22):250-77. PubMed ID: 30909
    [No Abstract]   [Full Text] [Related]  

  • 44. Structure-activity relationships of phenethylamine. a comparison of quantum mechanical SCF "Ab initio" and semiempirical calculations.
    Martín M; Carbó R; Petrongolo C; Tomasi J
    J Am Chem Soc; 1975 Mar; 97(6):1338-47. PubMed ID: 237048
    [No Abstract]   [Full Text] [Related]  

  • 45. [Computer and chemical synthesis].
    Bruns H
    Naturwissenschaften; 1979 Apr; 66(4):197-201. PubMed ID: 440442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Critical and non-critical structural elements in drugs].
    Simonis AM; Ariëns EJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):65-6. PubMed ID: 4231876
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantitative structure-pharmacokinetic relationships and drug design.
    Seydel JK; Schaper KJ
    Pharmacol Ther; 1981; 15(2):131-82. PubMed ID: 6124012
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6.
    de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC
    J Med Chem; 1999 May; 42(9):1515-24. PubMed ID: 10229622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipophilic character and biological activity of drugs. II. The parabolic case.
    Hansch C; Clayton JM
    J Pharm Sci; 1973 Jan; 62(1):1-21. PubMed ID: 4566530
    [No Abstract]   [Full Text] [Related]  

  • 50. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
    González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
    Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the conformation of acetylcholine and acetylthiocholine.
    Pullman B; Courriére P
    Mol Pharmacol; 1972 May; 8(3):371-3. PubMed ID: 5040934
    [No Abstract]   [Full Text] [Related]  

  • 52. Quantum crystallography in medicinal chemistry.
    Matta CF; Massa L
    Future Med Chem; 2018 Jul; 10(13):1525-1527. PubMed ID: 29992827
    [No Abstract]   [Full Text] [Related]  

  • 53. Conductance of channels opened by acetylcholine-like drugs in muscle end-plate.
    Colquhoun D; Dionne VE; Steinbach JH; Stevens CF
    Nature; 1975 Jan; 253(5488):204-6. PubMed ID: 1078602
    [No Abstract]   [Full Text] [Related]  

  • 54. AN ATTEMPT TO STUDY THE EFFECTS OF CHEMICAL STRUCTURE ON THE AFFINITY AND EFFICACY OF COMPOUNDS RELATED TO ACETYLCHOLINE.
    BARLOW RB; SCOTT KA; STEPHENSON RP
    Br J Pharmacol Chemother; 1963 Dec; 21(3):509-22. PubMed ID: 14110751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Unforseeable hazards of various drugs].
    Laroche C; Simon P; Fraisse B
    Munch Med Wochenschr; 1972 Sep; 114(38):1595-9. PubMed ID: 4678409
    [No Abstract]   [Full Text] [Related]  

  • 56. Conformational adaptability at GABA-sensitive inhibitory synapses.
    Steward EG; Clarke GR
    J Theor Biol; 1975 Aug; 52(2):493-8. PubMed ID: 1195752
    [No Abstract]   [Full Text] [Related]  

  • 57. A theoretical approach to structure-activity relationships of chloramphenicol and congeners.
    Höltje HD; Kier LB
    J Med Chem; 1974 Aug; 17(8):814-9. PubMed ID: 4845374
    [No Abstract]   [Full Text] [Related]  

  • 58. [TRIAL OF PATHOGENIC THERAPY OF SCHIZOPHRENIA BY AN ACETYLCHOLINE-LIKE AGENT: OXOTREMORINE].
    COLLARD J; LECOQ R; DEMARET A
    Acta Neurol Psychiatr Belg; 1965 Feb; 65():122-7. PubMed ID: 14345524
    [No Abstract]   [Full Text] [Related]  

  • 59. Conformational flexibility in physiologically active amines.
    Richards WG; Aschman DG; Hammond J
    J Theor Biol; 1975 Jul; 52(1):223-30. PubMed ID: 168441
    [No Abstract]   [Full Text] [Related]  

  • 60. [Muscarinic agonists do not alter the process of spontaneous quantum secretion of the mediator from motor nerve endings in the frog].
    Nikol'skiĭ EE; Bukharaeva EA
    Biull Eksp Biol Med; 1987 Feb; 103(2):183-5. PubMed ID: 2880613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.